CS241149B2 - Method of 5-/(2-alkoxyphenyl/)thiazolidindiones preparation - Google Patents

Method of 5-/(2-alkoxyphenyl/)thiazolidindiones preparation Download PDF

Info

Publication number
CS241149B2
CS241149B2 CS84385A CS38584A CS241149B2 CS 241149 B2 CS241149 B2 CS 241149B2 CS 84385 A CS84385 A CS 84385A CS 38584 A CS38584 A CS 38584A CS 241149 B2 CS241149 B2 CS 241149B2
Authority
CS
Czechoslovakia
Prior art keywords
compound
alkoxyphenyl
methyl
formula
hydrogen
Prior art date
Application number
CS84385A
Other languages
Czech (cs)
English (en)
Other versions
CS38584A2 (en
Inventor
Rodney C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS38584A2 publication Critical patent/CS38584A2/cs
Publication of CS241149B2 publication Critical patent/CS241149B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Paints Or Removers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CS84385A 1983-01-17 1984-01-17 Method of 5-/(2-alkoxyphenyl/)thiazolidindiones preparation CS241149B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45868483A 1983-01-17 1983-01-17

Publications (2)

Publication Number Publication Date
CS38584A2 CS38584A2 (en) 1985-07-16
CS241149B2 true CS241149B2 (en) 1986-03-13

Family

ID=23821708

Family Applications (1)

Application Number Title Priority Date Filing Date
CS84385A CS241149B2 (en) 1983-01-17 1984-01-17 Method of 5-/(2-alkoxyphenyl/)thiazolidindiones preparation

Country Status (26)

Country Link
EP (1) EP0117035B1 (de)
JP (1) JPS59137474A (de)
KR (1) KR870001267B1 (de)
AT (1) ATE45574T1 (de)
AU (1) AU539921B2 (de)
CA (1) CA1233470A (de)
CS (1) CS241149B2 (de)
DD (1) DD216012A5 (de)
DE (1) DE3479419D1 (de)
DK (1) DK17984A (de)
EG (1) EG16563A (de)
ES (1) ES8506663A1 (de)
FI (1) FI840155A (de)
GR (1) GR79763B (de)
GT (1) GT198400006A (de)
HU (1) HU191265B (de)
IE (1) IE56842B1 (de)
IL (1) IL70690A (de)
NO (1) NO162462C (de)
NZ (1) NZ206845A (de)
PH (1) PH18882A (de)
PL (1) PL142152B1 (de)
PT (1) PT77958B (de)
SU (1) SU1189341A3 (de)
YU (1) YU43336B (de)
ZA (1) ZA84305B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007056A1 (en) 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
GB8910639D0 (en) * 1989-05-09 1989-06-21 Beecham Group Plc Novel compounds
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
PL3589636T3 (pl) * 2017-03-03 2024-02-19 Gilead Sciences, Inc. Sposoby wytwarzania inhibitorów acc i ich form stałych

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2263296A1 (de) * 1972-12-23 1974-06-27 Bayer Ag 4-alkyl-thiazol-2-one, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS56104876A (en) * 1980-01-24 1981-08-20 Takeda Chem Ind Ltd Thiazolidine derivative
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPS5728075A (en) * 1980-07-29 1982-02-15 Takeda Chem Ind Ltd Thiazolidine derivative
JPS5728073A (en) * 1980-07-29 1982-02-15 Takeda Chem Ind Ltd Inhibitor for aldose reducing enzyme
JPS57123175A (en) * 1981-01-26 1982-07-31 Takeda Chem Ind Ltd Preparation of thiazolidine derivative

Also Published As

Publication number Publication date
GR79763B (de) 1984-10-31
FI840155A0 (fi) 1984-01-16
JPS59137474A (ja) 1984-08-07
NO162462C (no) 1990-01-03
PT77958A (en) 1984-02-01
HU191265B (en) 1987-01-28
IL70690A0 (en) 1984-04-30
IL70690A (en) 1989-01-31
PL245745A1 (en) 1984-10-22
PL142152B1 (en) 1987-09-30
AU539921B2 (en) 1984-10-25
PT77958B (en) 1986-06-18
DE3479419D1 (en) 1989-09-21
DK17984A (da) 1984-07-18
IE56842B1 (en) 1992-01-01
ES528887A0 (es) 1985-08-01
FI840155A (fi) 1984-07-18
GT198400006A (es) 1985-07-06
YU43336B (en) 1989-06-30
PH18882A (en) 1985-10-22
EP0117035B1 (de) 1989-08-16
AU2328784A (en) 1984-07-19
DD216012A5 (de) 1984-11-28
ATE45574T1 (de) 1989-09-15
KR870001267B1 (ko) 1987-06-30
NZ206845A (en) 1986-09-10
EP0117035A2 (de) 1984-08-29
KR840007223A (ko) 1984-12-06
ES8506663A1 (es) 1985-08-01
IE840079L (en) 1984-07-17
CS38584A2 (en) 1985-07-16
JPH0329073B2 (de) 1991-04-23
SU1189341A3 (ru) 1985-10-30
CA1233470A (en) 1988-03-01
YU6184A (en) 1986-06-30
EG16563A (en) 1989-06-30
DK17984D0 (da) 1984-01-16
NO840144L (no) 1984-07-18
NO162462B (no) 1989-09-25
EP0117035A3 (en) 1987-01-14
ZA84305B (en) 1985-08-28

Similar Documents

Publication Publication Date Title
EP0428312B1 (de) Hypoglykämische Oxazolidindion-Derivate
EP0319189B1 (de) Thiazolidindione als hypoglykämische und antiatherosklerotische Mittel
US4617312A (en) Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
US4342771A (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4200642A (en) Spiro-oxazolidindiones
IE51427B1 (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
AU701068B2 (en) Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents
JP2000226379A (ja) 置換２，４−チアゾリジオン誘導体、その製造方法およびそれを含む薬剤組成物
AU611610B2 (en) Pyridazinone derivatives
US4387101A (en) Thiazolidine derivatives and their use
US4430337A (en) Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
CS241149B2 (en) Method of 5-/(2-alkoxyphenyl/)thiazolidindiones preparation
US4753956A (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4689336A (en) Hypoglycemic 5-substituted oxazolidine 2,4-diones
KR860001581B1 (ko) 스피로-3-헤테로-아졸론의 제조방법
EP0091761B1 (de) Thiazolidinderivate und ihre Herstellung
EP0591252B1 (de) Thiazolidindione als hypoglykämische wirkstoffe
US4457939A (en) Aldose reductase inhibiting 5-(2-alkoxy-3-substituted phenyl)hydantoins
US4812471A (en) Hypoglycemic 5-(isoxazolyl or isothiazolyl)-oxazolidine-2,4-diones
US5401761A (en) Thiazolidinedione hypoglycemic agents
EP0112620B1 (de) 5-(Substituierte Phenyl)-Hydantoine
US4786640A (en) 2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose reductase inhibitors
US4431810A (en) Intermediates for the preparation of 5-substituted oxazolidine-2,4-diones
KR830000329B1 (ko) 스피로-옥사졸리딘디온의 제조방법
KR850000384B1 (ko) 5-치환된 옥사졸리딘-2, 4-디온의 제조방법